SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-16-616660
Filing Date
2016-06-08
Accepted
2016-06-08 16:16:05
Documents
1
Effectiveness Date
2016-06-08

Document Format Files

Seq Description Document Type Size
1 DEFA14A d205852ddefa14a.htm DEFA14A 25364
  Complete submission text file 0001193125-16-616660.txt   26463
Mailing Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121
Business Address 9380 JUDICIAL DRIVE SAN DIEGO CA 92121 858-210-3700
Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)

IRS No.: 330344842 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36150 | Film No.: 161703745
SIC: 8731 Services-Commercial Physical & Biological Research